Navigation Links
State of Arkansas Department of Human Services, Division of Medical Services Selects U.S. Care Management for High-Risk Obstetrics Health Management Program
Date:11/20/2007

JACKSONVILLE, Fla., Nov. 20 /PRNewswire/ -- The State of Arkansas Department of Human Services, Division of Medical Services has selected U.S. Care Management (formally Specialty Disease Management) to provide obstetrical and infant health management services to assist in improving birth outcomes and reducing costs associated with complicated pregnancies, pre-term births and high-risk infants among Medicaid participants in Crittenden, Phillips and St. Francis Counties, Arkansas. The pilot program, called BirthWait(R), began in June 2007 and will continue for two years.

"High-risk pregnancies and pre-term deliveries often result in poor health outcomes for mother's and their infant's health, and additional costs to the family and our communities," said Roy Jeffus, director, Arkansas Department of Human Services, Division of Medical Services. "U.S. Care Management's intensive obstetrical and high risk infant health management services will contribute to efforts in Crittenden, Phillips and St. Francis counties to potentially reduce these costs and improve health outcomes."

U.S. Care Management, a wholly-owned subsidiary of U.S. Preventive Medicine, will utilize its unique community-based approach to identify persons who are likely to have a high-risk pregnancy and at-risk infants up to one year of age. Each person in the program will be assigned a community-based registered nurse who will provide care coordination, assessments, extensive education and monitoring. BirthWait(R) nurses utilize a case management database system, Casewatch(R) that includes guidelines and indicators for high risk pregnancy as well as other chronic conditions the mother may have including diabetes, hypertension, asthma and others. The system offers the same capabilities for at-risk infants. Nurses enter assessment information, develop individualized care plans, and document and report all contacts and interventions as well as the tracking of key indicators.

U.S. Care
'/>"/>

SOURCE U.S. Care Management
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. First biomarker discovered that predicts prostate cancer outcome
3. Frequent Prostate Screens Fail to Improve Aggressive Cancer Diagnoses
4. New male sling procedure helps prostate cancer survivors who suffer from urinary incontinence
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
7. 4-Star Gen. Barry Mccaffrey, Former U.S. Drug Czar, to Keynote Recovery Happens! Rally for Treatment: Wed., Sept. 5, 11 Am, State Capitol West Steps, Sacramento
8. Expert on Emerging Infectious Zoonotic Diseases Joining K-State as a Regents Distinguished Professor
9. Red wine compound shown to prevent prostate cancer
10. Universal Health Care Coverage in the United States
11. Olympic Gold Medalist Marion Jones-Thompson Pleads Guilty to Making False Statements in Two Separate Federal Criminal Investigations

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...K BROOK, Ill. November 23, 2009 In the November ...nthly peer-reviewed scientific journal of the Amer..., a study out of Stanford University found that Ba...symptomatic women undergoing endoscopic screening....ic ultrasound (EUS): Researchers from France, in t...
(Date:11/23/2009)...e generation of new nerve cells in the brain is re...affects the stem cells, maturation into nerve cell...erve cells through the brain tissue, reveals new r...the journal Stem Cells . , Although the researc...ls, it could lead to a new medicine for human bein...
(Date:11/23/2009)...gusta, Ga. - The Medical College of Georgia is lea... shift in the care of patients with sickle cell di...e and University of Florida are partners in the in... across Georgia to serve as "medical homes" for pa...ain crisis sends them to the hospital and seeking ...
(Date:11/23/2009)...acksburg, Va. The United States Department of Agr...rant to Virginia Tech and the University of Minnes...ticated turkey, Meleagris gallopavo. The funding w...tium to complete the genome sequencing using next-...me sequence, and identify genes and functions in t...
(Date:11/23/2009)... What could have been a simpl...David Perecman turns into a murder charge. , ...2009 -- What would have been a case for New York ...instead after an incident of road rage turned fata..., on Tuesday, a Brooklyn driver was shot and kille...
Breaking Medicine News(10 mins):Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 2Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 3Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 4Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 5Health News:Initiative could result in paradigm shift in the care of sickle cell patients 2Health News:Initiative could result in paradigm shift in the care of sickle cell patients 3Health News:Initiative could result in paradigm shift in the care of sickle cell patients 4Health News:Initiative could result in paradigm shift in the care of sickle cell patients 5Health News:Turkey Genome Sequencing Consortium awarded $0.9 million from USDA 2Health News:An Incident of Road Rage Turns Into Murder 2
...a dozen people have taken ill and have been hospit...nce//, is dismissed as ‘false’ and ‘ baseless’ by ...ngzhou. He further confirmed there was no in...s carried by a famous Hong-Kong daily that the Eig...
...DS Healthcare Foundation on Monday is expected to ...st the pharmaceutical company Pfizer//. The decisi...onal use of its erectile dysfunction drug Viagra i...es of HIV and other sexually transmitted infection...
... promote Kerala as an ideal destination for medica... hold// road shows in the US, Britain, Dubai, Musc...policy is required for this because it has to be s...would become the first state in the country to hav...
...n the Sydney CBD is linked to the Royal Automobile...orities suspect//. However, they could not confirm...l disease caused by a bacteria belonging to the Le...s Eve. RAC building had recorded a legionella ...
...rsity and pediatric specialists at Baylor College ...e's famed buckyball nanoparticles as passkeys that...search appears in the Jan. 21 issue of the journal...ctive cocoon around the cell's inner machinery and...
...s have shown that a drug commonly used to lower bl...lly engineered mice with Marfan syndrome and also ... muscular dystrophy. The results are reported ...ramatically strengthens the aorta, the major arter...
Other Medicine News:Health News:AIDS Healthcare Foundation to File Lawsuit Against Pfizer 2Health News:Buckyballs Used as 'Passkey' into Cancer Cells 2Health News:Common BP Drug Treats Muscular Dystrophy 2Health News:Common BP Drug Treats Muscular Dystrophy 3
(Date:11/23/2009)...e-FirstCall/--Pharmasset,Inc.(Nasdaq: VRUS )announ...Roche(SWX:ROG.VX;RO.S,OTCQX:RHHBY),willcontinuefor...ase2btrialofRG7128,afirst-in-classnucleosideanalog...isCvirus(HCV)infection.Thedecisionwasreachedaftera...tee(DMC)ofallavailablesafetydatafromthefirstcohort...
(Date:11/23/2009)...-FirstCall/--RaptorPharmaceuticalCorp.("Raptor"ort...romaPhase2bclinicaltrialofitsproprietarydelayed-re...swithnephropathiccystinosis("cystinosis").Thetrial...SD")GeneralClinicalResearchCenter,evaluatedsafety,...asingledoseofDRCysteamineinninecystinosispatients....
(Date:11/23/2009)...wire-FirstCall/--Oceanside Pharmaceuticals ,partof...todayannouncedthatithasnowlaunchedchlordiazepoxide...ic(AG)versionofLibrax®.Oceansidehasreceivedit...ibrax®genericmarket. ,, "Valeant,sOceansid...withitssuccessfullaunchanddistributionof5%fluorour...
Breaking Medicine Technology:Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 2Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 3Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 5Oceanside Pharmaceuticals Announces Launch of Librax(R) AG 2RF Technologies Achieves Premier Certification From Cisco in United States 52288 1RF Technologies Achieves Premier Certification From Cisco in United States 52288 2Young Black Hispanic Women Tend to Develop Love Handles 52284 1Young Black Hispanic Women Tend to Develop Love Handles 52284 2THA Honors 12 Legislators for Contributions to Health Care 52280 1THA Honors 12 Legislators for Contributions to Health Care 52280 2
... Ill., Sept. 22 Baxter Healthcare,Corporation tod...ial,following U.S. Food and Drug Administration (F...tion to evaluate GAMMAGARD LIQUID [Immune,Globulin...an Union, for the,treatment of mild-to-moderate Al...e first of two pivotal Phase III trials required t...
...tario, Sept. 22 Helix BioPharma announced,today t...vals to open,clinical sites in Germany to expand u...ha-2b in patients with ano-genital warts, which is...o have received approval to open these additional,...Helix BioPharma. "The,opening of sites in Germany ...
Other Medicine Technology:Baxter Initiates Phase III Trial for the Treatment of Alzheimer's Disease 2Baxter Initiates Phase III Trial for the Treatment of Alzheimer's Disease 3Baxter Initiates Phase III Trial for the Treatment of Alzheimer's Disease 4Baxter Initiates Phase III Trial for the Treatment of Alzheimer's Disease 5Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 2Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 3Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 4
8-multi channel rack
...c PTFE membranes,Millex filter units with hydropho...ing filtration of gases, for venting of sterile co...c solutions. Ready-to-use sterile 25 mm Millex fil...ections; other filter units can be autoclaved prio...
...icity personal water system is an economical alter... water. In addition to the ongoing expense to purc...y applications may be at risk - as contamination c...lity to degrade over time. Simplicity ultrapure wa...
...r, , Ultrapure Water Quality On Demand, The Super-...lish" to water which has been pretreated by revers...lus systems consistently produce ultrapure water q...cations.,The Super-Q Plus water system features a ...
Medicine Products: